^
    Back
    Association details:
    Biomarker:PUDP overexpression
    Cancer:Hepatocellular Cancer
    Drug Class:Immunotherapy
    Direction:Resistant
    Evidence:
    Evidence Level:
    Resistant: C3 – Early Trials
    Source:
    Front Oncol
    Title:

    Bioinformatics Analysis Combined With Experiments Predicts PUDP as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Through Its Interaction With Tumor Microenvironment

    Published date:
    03/08/2022
    Excerpt:
    Our study demonstrated that HCC patients with high PUDP expression are less likely to benefit from immunotherapy...Collectively, our study demonstrated that high expression of PUDP suggested a poor prognosis and low response to immunotherapy…
    DOI:
    10.3389/fonc.2022.830174